TMEM50B and cancer: KIT, CDH1, LSM7, C21orf4, DDI2 mRNA expression levels were significantly different between benign and malignant tumors, p(KIT) < 0.0001; p(CDH1) = 0.004; p(LSM7) = 0.03; p(C21orf4) = 0.01; p(DDI2) = 0.0001.